Heart Biotech Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.65M

  • Investors
  • 4

Heart Biotech General Information

Description

Developer of regenerative implants designed to restore natural tissue function in cardiovascular patients. The company specializes in bioengineered scaffolds featuring cell-free regenerative materials, dynamic tissue-shaping design, and full resorption capability, enabling pediatric and adult patients to regenerate living heart valves that grow, adapt, and eliminate the need for repeat surgeries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17 North Drive
  • Littleton
  • Winchester SO22 6QA
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Other Healthcare Services
Vertical(s)
Corporate Office
  • 17 North Drive
  • Littleton
  • Winchester SO22 6QA
  • England, United Kingdom

Heart Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Heart Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 10-Nov-2025 $2.65M Completed Pre-Clinical Trials
5. Grant 10-Jul-2025 Completed Startup
4. Grant 01-Dec-2024 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2025 Completed Startup
2. Later Stage VC 25-Nov-2024 $1.54M $3.75M Completed Pre-Clinical Trials
1. Angel (individual) 11-Nov-2014 $2.21M $2.21M Completed Product In Beta Test
To view Heart Biotech’s complete valuation and funding history, request access »

Heart Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Heart Biotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Heart Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of regenerative implants designed to restore natural tissue function in cardiovascular patients. The company s
Biotechnology
Winchester, United Kingdom
5 As of 2025

Eindhoven, Netherlands
 

Milan, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Heart Biotech Competitors (4)

One of Heart Biotech’s 4 competitors is Xeltis, a Venture Capital-Backed company based in Eindhoven, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xeltis Venture Capital-Backed Eindhoven, Netherlands
Corcym Private Equity-Backed Milan, Italy
Edwards Lifesciences Corporation Irvine, CA
Medtronic Corporation Minneapolis, MN
To view Heart Biotech’s complete competitors history, request access »

Heart Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Heart Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
Innovate UK Government
Norn Ventures Venture Capital Minority
Sharjah Research Technology and Innovation Park Corporation Minority
To view Heart Biotech’s complete investors history, request access »

Heart Biotech FAQs

  • When was Heart Biotech founded?

    Heart Biotech was founded in 2014.

  • Where is Heart Biotech headquartered?

    Heart Biotech is headquartered in Winchester, United Kingdom.

  • What is the size of Heart Biotech?

    Heart Biotech has 5 total employees.

  • What industry is Heart Biotech in?

    Heart Biotech’s primary industry is Biotechnology.

  • Is Heart Biotech a private or public company?

    Heart Biotech is a Private company.

  • What is Heart Biotech’s current revenue?

    The current revenue for Heart Biotech is .

  • How much funding has Heart Biotech raised over time?

    Heart Biotech has raised $6.4M.

  • Who are Heart Biotech’s investors?

    MedTech Innovator, Innovate UK, Norn Ventures, and Sharjah Research Technology and Innovation Park have invested in Heart Biotech.

  • Who are Heart Biotech’s competitors?

    Xeltis, Corcym, Edwards Lifesciences, and Medtronic are competitors of Heart Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process